Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market

Yuyu Pharma (CEO Robert Wonsang Yu, KRX the companythe companythe company22the company) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export COVID-Yuyu Pharma9 Test Kits to the Global Market. Leveraging Yuyu Pharma's global network, the company is in talks with several healthcare providers and leading hospitals to export the COVID-Yuyu Pharma9 kits.

Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market

US FDA gave Emergency Use Authorization (EUA) to STANDARD M nCoV Real-Time Detection Kit made by SD BIOSENSOR back in April 23, 2020. With the EUA, SD BIOSENSOR has the authority to supply STANDARD M nCoV Real-Time Detection Kit across the US. STANDARD M nCoV Real-Time Detection Kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. This is RT-PCR test that amplifies and diagnoses a specific gene sequence of COVID-19. Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market

Federal Emergency Management Agency (FEMA), an agency within the US Department of Homeland Security, has already purchased $5.2 million USD of SD Biosensor's test kits back in April 2020.

Hyo-Keun, Lee CEO of SD BIOSENSOR said that "We have been providing quality kits since 2010. Our HIV, Malaria and Syphilis test kits are already on the World Health Organization (WHO) list of prequalified in vitro diagnostic products. And we are proud to know that our COVID-19 kits will help facilitate in the fight against the spread of the coronavirus and possibly save lives. We will continue to provide quality products to help improve the health of all people around the world"

Robert Yu, CEO of Yuyu Pharma, said that "The partnership with SD BIOSENSOR will help provide much needed COVID-19 Kits to medical professionals. We hope our efforts will contribute in the fight against the coronavirus."

About Yuyu Pharma

Yuyu Pharma (KRX: 000220) is a pharmaceutical company founded in 1941. The company manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

Yuyu pharma contact Point
Global Sales Team
Franklin Park / [email protected]

Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-a
Caption - STANDARD(TM) M nCoV Real-Time Detection kit

Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-b
Caption - Yuyu Pharma Will Export COVID-19 Test Kits to the Global Market


ข่าวthe company+Yuyu Pharmaวันนี้

Duck Creek Technologies Appoints General Daniel Hokanson, USA, Ret. to Board of Directors

Duck Creek Technologies Decorated general brings extensive leadership and policy development expertise to board role Duck Creek Technologies , the global intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, has announced the appointment of General Daniel Hokanson, USA, Ret. to the company's board of directors. He brings deep expertise and experience in leading organizations through the development and implementation of detailed strategic policy

KTC has been upgraded to an "AA" corporat... KTC Delighted with New "AA" Rating from TRIS, Strengthening Its Path Toward Sustainable Growth — KTC has been upgraded to an "AA" corporate and debt ratin...

Kaspersky has launched a major update to ... Kaspersky Research Sandbox 3.0: more power, less hardware — Kaspersky has launched a major update to Kaspersky Research Sandbox, introducing version 3.0 w...

Electricity Generating Public Company Lim... EGCO Group boosts its renewables fleet with acquisition of 251 MW wind and solar farms in the US — Electricity Generating Public Company Limited or EGCO G...

The upgrade reflects CKPower's strengthen... CKPower's Debenture Credit Rating Upgraded to "A-" from "BBB+" by TRIS Rating — The upgrade reflects CKPower's strengthened debt structure, enhanced finan...

Thaioil and Krungthai Bank have signed a ... Thaioil and Krungthai Sign MOU on ESG-Linked FX Hedging to Drive Sustainable Organization — Thaioil and Krungthai Bank have signed a Memorandum of Underst...

Exotic Food Public Company Limited commit... Exotic Food Launches Climate Change Management Project - Transition to Net Zero 2050 — Exotic Food Public Company Limited commits to sustainable developme...